Search Within

Benoit Rousseau

  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (15)
  2. Meeting Abstract (4)
  3. Correspondence (2)
  4. Editorial (2)
  5. Research Letter (2)
  6. Review (2)
  7. Guidelines (1)
Groups
  1. Department of Medicine (28)
  2. Gastrointestinal Oncology Service (28)
  3. Sloan Kettering Institute Postdocs (28)
  4. Solid Tumor Oncology Division (28)
  5. Center for Pancreatic Cancer Research (24)
  6. Survivorship Research (15)

More Groups

People
  1. Luis Diaz (23)
  2. Andrea Cercek Hanjis (15)
  3. Guillermo Argiles Martinez (13)
  4. Michael Foote (13)
  5. Rona Yaeger (8)
  6. Neil Segal (7)

More People

Years
  1. 2025 (4)
  2. 2024 (5)
  3. 2023 (5)
  4. 2022 (4)
  5. 2021 (6)
  6. 2020 (3)

More Years

Publications
  1. Annals of Oncology (4)
  2. Journal of Clinical Oncology (4)
  3. New England Journal of Medicine (3)
  4. Cancer Discovery (2)
  5. Clinical Cancer Research (2)
  6. JAMA Oncology (2)

More Publications

Publishers
  1. American Association for Cancer Research (5)
  2. Oxford University Press (5)
  3. American Society of Clinical Oncology (4)
  4. American Medical Association (3)
  5. Massachusetts Medical Society (3)
  6. Nature Publishing Group (3)

More Publishers

Results (28)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD4 T cell-dependent rejection of beta-2 microglobulin null mismatch repair-deficient tumors
    Journal Article

    Germano, G.; Lu, S.; Rospo, G.; Lamba, S.; Rousseau, B.; Fanelli, S.; Stenech, D.; Le, D. T.; Hays, J.; Totaro, M. G.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Pharmacologic modulation of RNA splicing enhances anti-tumor immunity
    Journal Article

    Lu, S. X.; De Neef, E.; Thomas, J. D.; Sabio, E.; Rousseau, B.; Gigoux, M.; Knorr, D. A.; Greenbaum, B.; Elhanati, Y.; Hogg, S. J.; more...
    Cell (2021)

    Fulltext@MSK | Save
  • The spectrum of benefit from checkpoint blockade in hypermutated tumors
    Research Letter

    Rousseau, B.; Foote, M. B.; Maron, S. B.; Diplas, B. H.; Lu, S.; Argilés, G.; Cercek, A.; Diaz, L. A. Jr
    New England Journal of Medicine (2021)

    Fulltext@MSK | Save
  • DNA sensing in mismatch repair-deficient tumor cells is essential for anti-tumor immunity
    Journal Article

    Lu, C.; Guan, J.; Lu, S.; Jin, Q.; Rousseau, B.; Lu, T.; Stephens, D.; Zhang, H.; Zhu, J.; Yang, M.; more...
    Cancer Cell (2021)

    Fulltext@MSK | Save
  • Evaluation of POLE/POLD1 variants as potential biomarkers for immune checkpoint inhibitor treatment outcomes
    Correspondence

    Rousseau, B.; Vidal, J.; Diaz, L. A. Jr
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Immune checkpoint inhibition in colorectal cancer: Microsatellite instability and beyond
    Review

    Cohen, R.; Rousseau, B.; Vidal, J.; Colle, R.; Diaz, L. A. Jr; André, T.
    Targeted Oncology (2020)

    Fulltext@MSK | Save
  • Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative
    Guidelines

    Cohen, R.; Vernerey, D.; Bellera, C.; Meurisse, A.; Henriques, J.; Paoletti, X.; Rousseau, B.; Alberts, S.; Aparicio, T.; Boukovinas, I.; more...
    European Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Clinicopathological and molecular criteria assessment for the screening of hypermutated proficient mismatch repair (pMMR) colorectal cancers (CRC) with exonucleasic domain POLE (edPOLE) mutations (mt)
    Meeting Abstract

    Rousseau, B. J. C.; Cohen, J.; Calderaro, J.; Dupuy, A.; Bourgoin, R.; Tournigand, C.; Baumgaertner, I.; Ropert, S.; Thirot Bidault, A.; Klotz, C.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save